Epilepsy Talk
The first new Alzheimer’s drug in 18 years may not work.
June 17, 2021
Leave a Comment
Leave a Comment
Getting the FDA to retract a decision is like getting the toothpaste back in the tub, after it’s been squeezed out…
Whether it’s “yes” or “no,” there is no “maybe so”.
A good example is the new all-star Alzheimer’s drug aducanumab.
Posted in Epilepsy, Medication Issues, News, Research
Tags: $5600 a year, aducanumab, Alzheimer's drug, amyloid plaque, billions of dollars, caregiver, FDA, Medicare, not proven
Tags: $5600 a year, aducanumab, Alzheimer's drug, amyloid plaque, billions of dollars, caregiver, FDA, Medicare, not proven
About the author
Epilepsy Talk 